Allogeneic mesenchymal stem cell therapy

· National Institute of Blood and Marrow Transplant (NIBMT)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic mesenchymal stem cell therapy, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. [Phase 1, Phase 2]

See pricing